Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
ALLO
— Allogene Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 14, 2026
REVENUE
$0
EPS
-$0.18
-5.9%
FREE CASH FLOW
-$12.9M
+53.2%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →